Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo- and active-controlled trial of JJH201501 for depression
CTR20241229Phase 3Completed
- Sponsor
- Jiangsu Jibeier Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of JJH201501 in major depressive disorder (MDD), sponsored by Jiangsu Jibeier Pharmaceutical. Started Apr 2024; status: completed.
02
Drugs
JJH201501
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20241229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241229.